Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Name / Ticker | Price | Zen Rating |
---|---|---|
$2.89 | A | |
$42.51 | A | |
$8.11 | A |